0001209191-21-061525.txt : 20211025
0001209191-21-061525.hdr.sgml : 20211025
20211025170610
ACCESSION NUMBER: 0001209191-21-061525
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211022
FILED AS OF DATE: 20211025
DATE AS OF CHANGE: 20211025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashburn Theodore
CENTRAL INDEX KEY: 0001627978
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39575
FILM NUMBER: 211344901
MAIL ADDRESS:
STREET 1: 1688 WASHINGTON STREET #1
CITY: BOSTON
STATE: MA
ZIP: 02118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncorus, Inc.
CENTRAL INDEX KEY: 0001671818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473779757
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 KENDALL STREET
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-425-9200
MAIL ADDRESS:
STREET 1: 450 KENDALL STREET
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-10-22
0
0001671818
Oncorus, Inc.
ONCR
0001627978
Ashburn Theodore
C/O ONCORUS, INC.
50 HAMPSHIRE STREET, SUITE 401
CAMBRIDGE
MA
02139
1
1
0
0
President and CEO
Common Stock
2021-10-22
4
M
0
43707
1.81
A
66852
D
Employee Stock Option (right to buy)
1.81
2021-10-22
4
M
0
43707
0.00
D
2028-11-13
Common Stock
43707
288268
D
Twenty-five percent (25%) of the shares subject to the option vested on July 16, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person's continued service through each such vesting date.
/s/ John McCabe, Attorney-in-Fact
2021-10-25